Page last updated: 2024-11-04

terbutaline and Zollinger-Ellison Syndrome

terbutaline has been researched along with Zollinger-Ellison Syndrome in 1 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Zollinger-Ellison Syndrome: A syndrome that is characterized by the triad of severe PEPTIC ULCER, hypersecretion of GASTRIC ACID, and GASTRIN-producing tumors of the PANCREAS or other tissue (GASTRINOMA). This syndrome may be sporadic or be associated with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thirlby, RC1
Richardson, CT1
Chew, P1
Feldman, M1

Other Studies

1 other study available for terbutaline and Zollinger-Ellison Syndrome

ArticleYear
Effect of terbutaline, a beta 2-adrenoreceptor agonist, on gastric acid secretion and serum gastrin concentrations in humans.
    Gastroenterology, 1988, Volume: 95, Issue:4

    Topics: Adult; Eating; Female; Gastric Acid; Gastrins; Humans; Injections, Subcutaneous; Male; Middle Aged;

1988